Aclarion downgraded to Hold from Buy at Maxim
Aclarion, Inc. (ACON)
Company Research
Source: The Fly
Impact Snapshot
Event Time:
ACON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACON alerts
High impacting Aclarion, Inc. news events
Weekly update
A roundup of the hottest topics
ACON
News
- Clinical Decision Support Systems Pipeline Report Featuring Over 300 Companies/Universities and Product Developments by Stages of Development, Segments, Region and Countries, Regulatory Path [Yahoo! Finance]Yahoo! Finance
- Aclarion, Inc. (NASDAQ: ACON) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand ViewingAccesswire
- Aclarion, Inc. (NASDAQ: ACON) had its price target lowered by analysts at Ascendiant Capital Markets from $1.50 to $1.30. They now have a "buy" rating on the stock.MarketBeat
- Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash [Yahoo! Finance]Yahoo! Finance
ACON
Sec Filings
- 12/11/24 - Form S-1
- 12/2/24 - Form DEF
- 11/27/24 - Form 8-K
- ACON's page on the SEC website